EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation

Laura Botta iD, Riccardo Capocaccia iD, Alice Bernasconi iD, Silvia Rossi iD, Jaume Galceran iD, Luigino Dal Maso iD, Come Lepage iD, Florence Molinié iD, Anne-Marie Bouvier iD, Rafael Marcos-Gragera iD, Claudia Vener iD, Marcela Guevara iD und 5 weitere

American Journal of Epidemiology · 2025

DOI: 10.1093/aje/kwaf148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Laura Botta und 16 weiteren Autor:innen. Beteiligte Einrichtung: Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Italian Association for Cancer Research, French Institut National du Cancer, Italian Association of Cancer Research (AIRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relative survival (RS) with the general population as the reference is commonly used to estimate net survival (NS). However, cancer patients may face an increased risk of noncancer death compared to cancer-free individuals. We evaluate the impact of considering this relative risk (RR) on NS estimation. First, we compared selected NS values to generated RS under various theoretical scenarios, considering different RR, NS, age at diagnosis, time since diagnosis, and sex. Then, differences between NS and RS for 3 cancers were analyzed from cure model-based estimates using EUROCARE-6 data. We observed differences between RS and the true value of NS, larger for longer time since diagnosis, older patients, and higher NS. For head and neck cancer, the smallest differences were for young female patients at 5 years from diagnosis (4%) and the highest (32%) for older patients. For colorectal cancer, differences were <7% for all ages, both sexes, and times since diagnosis and for breast cancer, differences were <5% except for older patients after 5 years. If RR > 1, RS underestimates NS. Our findings aim to correctly interpret the differences between RS and NS, and contextualize the possible biases of assuming RS as a proxy for cancer-specific survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsHumansFemaleMaleMiddle AgedAgedAdultBreast NeoplasmsSurvival AnalysisColorectal NeoplasmsHead and Neck NeoplasmsAge FactorsYoung AdultAged, 80 and over

Stichwörter der Autor:innen

net survivalpopulation-based cancer registryrelative risk of noncancer death for cancer patients compared to general popula…relative survival

Autor:innen und Institutionen

  • Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • INSERM CTM UMR 1231 EPICAD, University of Burgundy, Dijon, France.
  • Editorial Board, Epidemiologia e Prevenzione, Milan, Italy.
  • Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Tarragona Cancer Registry, Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, Reus, Spain.
  • Pere Virgili Health Research Institute, Reus, Spain.

ORCID-Profile: Laura Botta, Riccardo Capocaccia, Alice Bernasconi, Silvia Rossi, Jaume Galceran, Luigino Dal Maso, Come Lepage, Florence Molinié, Anne-Marie Bouvier, Rafael Marcos-Gragera, Claudia Vener, Marcela Guevara, Deirdre Murray, Rosalia Ragusa, Gemma Gatta, Valerie Jooste

Förderung

  • Italian Association for Cancer Research
  • French Institut National du Cancer
  • Italian Association of Cancer Research (AIRC)
  • Innovative Partnership for Action Against Cancer

Zitieren

APA

Botta, L., Capocaccia, R., Bernasconi, A., Rossi, S., Galceran, J., Dal Maso, L., Lepage, C., Molinié, F., Bouvier, A. M., Marcos-Gragera, R., Vener, C., Guevara, M., Murray, D., Ragusa, R., Gatta, G., Jooste, V., & EUROCARE-6 WG (2025). The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf148

Vancouver

Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Dal Maso L, et al. The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf148

BibTeX
@article{Botta2025,
  author = {Botta, Laura and Capocaccia, Riccardo and Bernasconi, Alice and Rossi, Silvia and Galceran, Jaume and Dal Maso, Luigino and Lepage, Come and Molinié, Florence and Bouvier, Anne-Marie and Marcos-Gragera, Rafael and Vener, Claudia and Guevara, Marcela and Murray, Deirdre and Ragusa, Rosalia and Gatta, Gemma and Jooste, Valerie and EUROCARE-6 WG, EUROCARE-6 WG},
  title = {The impact of cancer survivors’ extra risk of noncancer mortality on net survival estimation},
  journal = {American Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/aje/kwaf148}
}
Kostenlos starten →